Answers are grounded in this paper and cite their sources.
Elemental boron, an eco-friendly and cost-effective metalloid reductant, was employed as a reductive co-catalyst to accelerate Fe3+/Fe2+ redox cycling in Fe2+-initiated periodate (PI) activation for sulfamethazine (SMT) degradation. The standalone Fe2+/PI system achieved only 24.1% SMT elimination within 30 min, whereas the constructed B/Fe2+/PI system delivered up to 97.7% removal under an extremely low iron dosage (10 μM Fe2+) and acidic condition (pH 3.0). Radical quenching assays combined with molecular probe identification revealed the co-existence of Fe(IV), •OH, 1O2, O2•−, and IO3•−, with •OH, among which •OH was identified as the dominant oxidant, and its generation was notably amplified by boron. X-ray photoelectron spectroscopy (XPS) characterization demonstrated that surface B-B bonds and low-valent boron moieties act as electron donors to reduce Fe3+ to Fe2+, sustaining continuous Fe3+/Fe2+ redox turnover. Eight transformation intermediates were identified by mass spectrometry, based on which plausible degradation pathways for SMT were proposed. The B/Fe2+/PI system exhibited robust tolerance against prevalent inorganic anions, maintained favorable catalytic capability in natural lake water, and preserved stable performance across five successive recycling runs. Accordingly, boron-augmented Fe2+-triggered periodate activation represents a promising low-iron technical paradigm for antibiotic remediation in water environments.
No takes yet. Share an insight, caveat, or question.
Bu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: